Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
Determining Disease Activity Biomarkers in Individuals With Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
This observational or N/A phase trial investigates Granulomatosis With Polyangiitis and Microscopic Polyangiitis and is currently completed. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) leads this study, which shows 16 recorded versions since 2006 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Dec 2021 — Sep 2022 [monthly]
Active Not Recruiting
-
Jun 2021 — Dec 2021 [monthly]
Active Not Recruiting
▶ Show 11 earlier versions
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jun 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Nov 2019 — Jun 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2019 — Nov 2019 [monthly]
Recruiting
-
Apr 2019 — Jun 2019 [monthly]
Recruiting
-
Jun 2018 — Apr 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Apr 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Office of Rare Diseases (ORD)
- Rare Diseases Clinical Research Network
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Boston, United States
- • Cleveland, United States
- • Hamilton, Canada
- • Philadelphia, United States
- • Pittsburgh, United States
- • Rochester, United States
- • Salt Lake City, United States
- • Toronto, Canada